Home
Archives
Jerusalem Center Homepage
View the current issue
Jerusalem Center Videos
Additional Resources
Top Commentators:
- Elliott Abrams
- Fouad Ajami
- Shlomo Avineri
- Benny Avni
- Alan Dershowitz
- Jackson Diehl
- Dore Gold
- Daniel Gordis
- Tom Gross
- Jonathan Halevy
- David Ignatius
- Pinchas Inbari
- Jeff Jacoby
- Efraim Karsh
- Mordechai Kedar
- Charles Krauthammer
- Emily Landau
- David Makovsky
- Aaron David Miller
- Benny Morris
- Jacques Neriah
- Marty Peretz
- Melanie Phillips
- Daniel Pipes
- Harold Rhode
- Gary Rosenblatt
- Jennifer Rubin
- David Schenkar
- Shimon Shapira
- Jonathan Spyer
- Gerald Steinberg
- Bret Stephens
- Amir Taheri
- Josh Teitelbaum
- Khaled Abu Toameh
- Jonathan Tobin
- Michael Totten
- Michael Young
- Mort Zuckerman
Think Tanks:
- American Enterprise Institute
- Brookings Institution
- Center for Security Policy
- Council on Foreign Relations
- Heritage Foundation
- Hudson Institute
- Institute for Contemporary Affairs
- Institute for Counter-Terrorism
- Institute for Global Jewish Affairs
- Institute for National Security Studies
- Institute for Science and Intl. Security
- Intelligence and Terrorism Information Center
- Investigative Project
- Jerusalem Center for Public Affairs
- RAND Corporation
- Saban Center for Middle East Policy
- Shalem Center
- Washington Institute for Near East Policy
Media:
- CAMERA
- Daily Alert
- Jewish Political Studies Review
- MEMRI
- NGO Monitor
- Palestinian Media Watch
- The Israel Project
- YouTube
Government:
Back
(Israel21c) Abigail Klein Leichman - ImmunoXpert, developed by Israeli startup MeMed, is now used by hospitals in the EU, Switzerland and Israel to determine rapidly whether an infection is bacterial or viral. Because they are usually unable to determine the cause of an infection, many physicians prescribe antibiotics to be on the safe side. Experts believe that up to 50% of antibiotic drug regimens are unnecessary or inappropriate. And antibiotic overuse is a major trigger for drug-resistant strains estimated to kill 50,000 people each year in Europe and the U.S. ImmunoXpert interprets chemical signals from the body's own immune system to distinguish with over 90% accuracy between bacterial and viral infections. Instead of trying to access and isolate the pathogen, ImmunoXpert's sophisticated biosensors and algorithms decode the immune system's distinct responses to bacterial and viral infections.2016-10-11 00:00:00Full Article
New Diagnostic Test Distinguishes Bacterial from Viral Infections
(Israel21c) Abigail Klein Leichman - ImmunoXpert, developed by Israeli startup MeMed, is now used by hospitals in the EU, Switzerland and Israel to determine rapidly whether an infection is bacterial or viral. Because they are usually unable to determine the cause of an infection, many physicians prescribe antibiotics to be on the safe side. Experts believe that up to 50% of antibiotic drug regimens are unnecessary or inappropriate. And antibiotic overuse is a major trigger for drug-resistant strains estimated to kill 50,000 people each year in Europe and the U.S. ImmunoXpert interprets chemical signals from the body's own immune system to distinguish with over 90% accuracy between bacterial and viral infections. Instead of trying to access and isolate the pathogen, ImmunoXpert's sophisticated biosensors and algorithms decode the immune system's distinct responses to bacterial and viral infections.2016-10-11 00:00:00Full Article
Search Daily Alert
|
Search:
|